|
1
|
Miyamoto T, Carrero JJ and Stenvinkel P:
Inflammation as a risk factor and target for therapy in chronic
kidney disease. Curr Opin Nephrol Hypertens. 20:662–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O’Seaghdha CM and Foley RN: Septicemia,
access, cardiovascular disease, and death in dialysis patients.
Perit Dial Int. 25:534–540. 2005.PubMed/NCBI
|
|
3
|
Hakim RM and Himmerlfarb J: Hemodialysis
access failure: a call to action. Kidney Int. 54:1029–1040. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Kidney Foundation. K/DOQI
clinical practice guidelines for chronic kidney disease:
evaluation, classification, and stratification. Am J Kidney Dis.
39(2 Suppl 1): S1–S266. 2002.PubMed/NCBI
|
|
5
|
Soni R, Horowitz B and Unruh M:
Immunization in end-stage renal disease: opportunity to improve
outcomes. Semin Dial. 26:416–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Delmez JA, Yan G, Bailey J, et al:
Cerebrovascular disease in maintenance hemodialysis patients:
results of the HEMO Study. Am J Kidney Dis. 47:131–138. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarnak MJ and Jaber BL: Mortality caused
by sepsis in patients with end-stage renal disease compared with
the general population. Kidney Int. 58:1758–1764. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarnak MJ and Jaber BL: Pulmonary
infectious mortality among patients with end-stage renal disease.
Chest. 120:1883–1887. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rayner HC, Pisoni RL, Bommer J, et al:
Mortality and hospitalization in haemodialysis patients in five
European countries: results from the Dialysis Outcomes and Practice
Patterns Study (DOPPS). Nephrol Dial Transplant. 19:108–120. 2004.
View Article : Google Scholar
|
|
10
|
Peddi S, Ram R, Boreddy VD, Avssn S,
Chennu KK and Vishnubotla SK: Multiple metastatic infections in a
hemodialysis patient with untunneled internal jugular catheter.
Hemodial Int. June.18–2013.(Epub ahead of print).
|
|
11
|
Kraśniak A, Drozdz M, Pasowicz M, et al:
Factors involved in vascular calcification and atherosclerosis in
maintenance haemodialysis patients. Nephrol Dial Transplant.
22:515–521. 2007.PubMed/NCBI
|
|
12
|
Qureshi AR, Alvestrand A, Divino-Filho JC,
et al: Inflammation, malnutrition, and cardiac disease as
predictors of mortality in hemodialysis patients. J Am Soc Nephrol.
13(Suppl 1): S28–S36. 2002.PubMed/NCBI
|
|
13
|
Zelaźnicka M, Kocelak P, Olszanecka
Glinianowicz M and Chudek J: Cinacalcet therapy and cardiovascular
risk in hemodialysis patients. Postepy Hig Med Dosw (Online).
66:722–729. 2012.(In Polish).
|
|
14
|
Ulasli SS, Ulubay G, Arslan NG, et al:
Characteristics and outcomes of end-stage renal disease patients
with active tuberculosis followed in intensive care units. Saudi J
Kidney Dis Transpl. 20:254–259. 2009.PubMed/NCBI
|
|
15
|
Bell M, Granath F, Schön S, et al:
End-stage renal disease patients on renal replacement therapy in
the intensive care unit: short- and long-term outcome. Crit Care
Med. 36:2773–2778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joseph NM, Sistla S, Dutta TK, et al:
Ventilator-associated pneumonia in a tertiary care hospital in
India: role of multi-drug resistant pathogens. J Infect Dev Ctries.
4:218–225. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Werarak P, Kiratisin P and Thamlikitkul V:
Hospital-acquired pneumonia and ventilator-associated pneumonia in
adults at Siriraj Hospital: etiology, clinical outcomes, and impact
of antimicrobial resistance. J Med Assoc Thai. 93(Suppl 1):
S126–S138. 2010.
|
|
18
|
Michalopoulos A and Falagas ME: Treatment
of Acinetobacter infections. Expert Opin Pharmacother. 11:779–788.
2010. View Article : Google Scholar
|
|
19
|
Vandecasteele SJ and De Vriese AS: Recent
changes in vancomycin use in renal failure. Kidney Int. 77:760–764.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thorn KA, Johnson JA, Strauss SM, et al:
Increasing prevalence of gastrointestinal colonization with
ceftazidime-resistant gram-negative bacteria among intensive care
unit patients. Infect Control Hosp Epidemiol. 28:1240–1246. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rhee JY, Park YK, Shin JY, et al:
KPC-producing extreme drug-resistant Klebsiella pneumoniae
isolate from a patient with diabetes mellitus and chronic renal
failure on hemodialysis in South Korea. Antimicrob Agents
Chemother. 54:2278–2279. 2010.PubMed/NCBI
|
